These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 23555668)

  • 1. Prevalence of heterotypic tumor/immune cell-in-cell structure in vitro and in vivo leading to formation of aneuploidy.
    Chen YH; Wang S; He MF; Wang Y; Zhao H; Zhu HY; Yu XM; Ma J; Che XJ; Wang JF; Wang Y; Wang XN
    PLoS One; 2013; 8(3):e59418. PubMed ID: 23555668
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antileukemia activity of a natural killer cell line against human leukemias.
    Yan Y; Steinherz P; Klingemann HG; Dennig D; Childs BH; McGuirk J; O'Reilly RJ
    Clin Cancer Res; 1998 Nov; 4(11):2859-68. PubMed ID: 9829753
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The 5' flanking region of the human granzyme H gene directs expression to T/natural killer cell progenitors and lymphokine-activated killer cells in transgenic mice.
    MacIvor DM; Pham CT; Ley TJ
    Blood; 1999 Feb; 93(3):963-73. PubMed ID: 9920846
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Rapid reuptake of granzyme B leads to emperitosis: an apoptotic cell-in-cell death of immune killer cells inside tumor cells.
    Wang S; He MF; Chen YH; Wang MY; Yu XM; Bai J; Zhu HY; Wang YY; Zhao H; Mei Q; Nie J; Ma J; Wang JF; Wen Q; Ma L; Wang Y; Wang XN
    Cell Death Dis; 2013 Oct; 4(10):e856. PubMed ID: 24113190
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Analysis of the relationship between stage of differentiation and NK/LAK susceptibility of colon carcinoma cells.
    Blottière HM; Zennadi R; Grégoire M; Aillet G; Denis MG; Meflah K; Le Pendu J
    Int J Cancer; 1993 Feb; 53(3):409-17. PubMed ID: 8428794
    [TBL] [Abstract][Full Text] [Related]  

  • 6. T cells and monocytes regulate the generation and functional activity of natural killer-derived lymphokine-activated killer cells.
    Atzpodien J; Gulati SC
    Stem Cells; 1993 Nov; 11(6):511-8. PubMed ID: 8111310
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Human tumor cell line resistance to chemotherapeutic agents does not predict resistance to natural killer or lymphokine-activated killer cell-mediated cytolysis.
    Harker WG; Tom C; McGregor JR; Slade L; Samlowski WE
    Cancer Res; 1990 Sep; 50(18):5931-6. PubMed ID: 1975512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cytolytic activity of natural killer cells and lymphokine activated killer cells against hepatitis A virus infected fibroblasts.
    Baba M; Hasegawa H; Nakayabu M; Fukai K; Suzuki S
    J Clin Lab Immunol; 1993; 40(2):47-60. PubMed ID: 7932628
    [TBL] [Abstract][Full Text] [Related]  

  • 9. P-glycoprotein-mediated multidrug resistance and lymphokine-activated killer cell susceptibility in ovarian carcinoma.
    Savas B; Cole SP; Tsuruo T; Pross HF
    J Clin Immunol; 1996 Nov; 16(6):348-57. PubMed ID: 8946280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Endogenous and adoptively transferred A-NK and T-LAK cells continuously accumulate within murine metastases up to 48 h after inoculation.
    Hokland M; Kjaergaard J; Kuppen PJ; Nannmark U; Agger R; Hokland P; Basse P
    In Vivo; 1999; 13(3):199-204. PubMed ID: 10459491
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mechanism of interferon gamma-induced protection of human gliosarcoma cells from lymphokine-activated killer lysis: division of lymphokine-activated killer cells into natural killer- and T-like cells.
    Kondo S; Miyatake S; Kikuchi H; Oda Y; Iwasaki K; Ohyama K; Namba Y
    Neurosurgery; 1992 Sep; 31(3):534-40. PubMed ID: 1407434
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of equine natural killer and IL-2 stimulated lymphokine activated killer cell populations.
    Viveiros MM; Antczak DF
    Dev Comp Immunol; 1999 Sep; 23(6):521-32. PubMed ID: 10512462
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VLA-6 (CDw49f) is an important adhesion molecule in NK cell-mediated cytotoxicity following autologous or allogeneic bone marrow transplantation.
    Lowdell MW; Shamim F; Hamon M; Macdonald ID; Prentice HG
    Exp Hematol; 1995 Dec; 23(14):1530-4. PubMed ID: 8542943
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cellular cytotoxicity of human natural killer cells and lymphokine-activated killer cells against bladder carcinoma cell lines.
    Wang MH; Flad HD; Böhle A; Chen YQ; Ulmer AJ
    Immunol Lett; 1991 Mar; 27(3):191-7. PubMed ID: 2060970
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Bovine NK and LAK susceptibility is independent of class I expression on B lymphoblastoid variants.
    Li W; Splitter GA
    Vet Immunol Immunopathol; 1994 Jun; 41(3-4):189-200. PubMed ID: 7941303
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cooperation of liver cells in health and disease.
    Kmieć Z
    Adv Anat Embryol Cell Biol; 2001; 161():III-XIII, 1-151. PubMed ID: 11729749
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-4-induced lymphokine-activated killer cells. Lytic activity is mediated by phenotypically distinct natural killer-like and T cell-like large granular lymphocytes.
    Peace DJ; Kern DE; Schultz KR; Greenberg PD; Cheever MA
    J Immunol; 1988 May; 140(10):3679-85. PubMed ID: 2896213
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Factors determining the ability of cytokine-activated killer cells to lyse human ovarian carcinoma targets.
    Hirte HW; Clark DA
    Cell Immunol; 1991 Aug; 136(1):122-32. PubMed ID: 2060017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Human pulmonary natural killer (NK) cells exhibit limited lymphokine-activated killer (LAK) activity.
    Yarbrough WC; Weissler JC
    Am J Respir Cell Mol Biol; 1989 Oct; 1(4):305-11. PubMed ID: 2483121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Distinct characteristics of lymphokine-activated killer (LAK) cells derived from patients with B-cell chronic lymphocytic leukemia (B-CLL). A factor in B-CLL serum promotes natural killer cell-like LAK cell growth.
    Santiago-Schwarz F; Panagiotopoulos C; Sawitsky A; Rai KR
    Blood; 1990 Oct; 76(7):1355-60. PubMed ID: 2207313
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.